At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program

• मुख्य लेखकों: Sonia Ruiz-Boy (लेखक), Alexandra Pedraza (लेखक), Marta Prat (लेखक), Maria Queralt Salas (लेखक), Esther Carcelero (लेखक), Gisela Riu-Viladoms (लेखक), María Suárez-Lledó (लेखक), Inés Monge-Escartín (लेखक), Luis Gerardo Rodríguez-Lobato (लेखक), Alexandra Martínez-Roca (लेखक), Montserrat Rovira (लेखक), Carmen Martínez (लेखक), Cristina Gallego (लेखक), Álvaro Urbano-Ispizua (लेखक), Joan Sánchez (लेखक), María Ángeles Marcos (लेखक), Francesc Fernández-Avilés (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2023-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Cytomegalovirus (CMV) infection is a relevant cause of morbimortality in patients receiving allogeneic stem cell transplantation (allo-HCT). Foscarnet (FCN) is an effective drug against CMV administered intravenously and usually on an inpatient basis. The Home Care Unit (HCU) for hematologic patient...